close

Object

Created by fda_medical_bot on 1/9/2012

/m/0hwy308

mid: /m/0hwy308

Add type

Metaweb System Types

Object

Medicine

Drug label section

Freebase

Object profile

Object is not asserted on this topic.

ID /type/object/id

-

GUID /type/object/guid

#9202a8c04000641f800000001fbe8c08

Type /type/object/type

Drug label section

Name /type/object/name

-

Key /type/object/key

-

Timestamp /type/object/timestamp

Monday, January 09, 2012 3:38 AM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

fda_medical_bot

Attribution /type/object/attribution

fda_medical_bot

Search /type/object/search

-

Machine ID /type/object/mid

/m/0hwy308

Section name /medicine/drug_label_section/section_name

- - Edit
  - Delete
7 Drug Interactions

Section URI /medicine/drug_label_section/section_uri

- - Edit
  - Delete
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=309de576-c318-404a-bc15-660c2b1876fb#s53

Prominent warning /medicine/drug_label_section/prominent_warning

- - Edit
  - Delete
false

Highlight text /medicine/drug_label_section/section_text

- - Edit
  - Delete
Monoamine Oxidase Inhibitors. (4.2, 7.1) CYP2D6 Inhibitors - Concomitant use may increase atomoxetine steady-state plasma concentrations in EMs. (7.2) Antihypertensive Drugs and Pressor Agents - Possible effects on blood pressure. (7.3) Albuterol (or other beta 2 agonists) - Action of albuterol on cardiovascular system can be potentiated. (7.4)

Subject manufactured drug /medicine/drug_label_section/subject_drug

Strattera 18,25,40,60 kit

Section LOINC code /medicine/drug_label_section/section_loinc_code

- - Edit
  - Delete
34073-7

Object profile is not asserted on this topic. Assert type now.

Object generation time /freebase/object_profile/object_generation_time

- - Edit
  - Delete
Saturday, May 18, 2013 8:48 PM

Link count /freebase/object_profile/link_count

-

Comments

Hide